Compare FOXX & ALUR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
| Metric | FOXX | ALUR |
|---|---|---|
| Founded | 2017 | 2009 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | | |
| Sector | | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 16.9M | 18.9M |
| IPO Year | N/A | N/A |
| Metric | FOXX | ALUR |
|---|---|---|
| Price | $4.31 | $1.73 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 2 |
| Target Price | N/A | ★ $9.25 |
| AVG Volume (30 Days) | 74.7K | ★ 77.4K |
| Earning Date | 02-13-2026 | 11-12-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $63,030,415.00 | $17,208,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $15.47 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 139.29 | N/A |
| 52 Week Low | $1.71 | $1.02 |
| 52 Week High | $11.00 | $16.81 |
| Indicator | FOXX | ALUR |
|---|---|---|
| Relative Strength Index (RSI) | 51.47 | 59.17 |
| Support Level | $4.00 | $1.18 |
| Resistance Level | $4.87 | $1.91 |
| Average True Range (ATR) | 0.54 | 0.14 |
| MACD | -0.02 | 0.05 |
| Stochastic Oscillator | 55.10 | 79.37 |
Foxx Development Holdings Inc is a consumer electronics and integrated Internet-of-Things (IoT) solution company catering to both retail and institutional clients. With robust research and development capabilities and a strategic commitment to cultivating long-term partnerships with mobile network operators, distributors, and suppliers. Its products include tablets, smartphones, wearables, and other high-quality communication terminals.
Allurion Technologies Inc is a medical device company that focuses on creating a weight loss platform to treat overweight patients. Its platform, the Allurion Program, features the world's first and only swallowable, procedure-less intragastric balloon for weight loss and offers access to AI-powered remote patient monitoring tools, a proprietary behavior change program, secure messaging, and video telehealth that are delivered by the Allurion VCS. Its proprietary intragastric balloon, the Allurion Balloon, is in the form of a swallowed capsule that is administered to patients under the guidance of a healthcare provider without surgery, endoscopy, or anesthesia.